Targeting Echinococcus multilocularis Stem Cells by Inhibition of the Polo-Like Kinase EmPlk1

作者: Andreas Schubert , Uriel Koziol , Katia Cailliau , Mathieu Vanderstraete , Colette Dissous

DOI: 10.1371/JOURNAL.PNTD.0002870

关键词:

摘要: Background: Alveolar echinococcosis (AE) is a life-threatening disease caused by larvae of the fox-tapeworm Echinococcus multilocularis. Crucial to AE pathology continuous infiltrative growth parasite’s metacestode stage, which driven population somatic stem cells, called germinative cells. Current anti-AE chemotherapy using benzimidazoles ineffective in eliminating cell population, thus leading remission parasite upon therapy discontinuation. Methodology/Principal findings: We herein describe characterization EmPlk1, encoded gene emplk1, displays significant homologies members Plk1 sub-family Polo-like kinases that regulate mitosis eukaryotic demonstrate cell-specific expression emplk1 RT-PCR, transcriptomics, and situ hybridization. also show EmPlk1 can induce germinal vesicle breakdown when heterologously expressed Xenopus oocytes, indicating it an active kinase. This activity was significantly suppressed presence BI 2536, inhibitor has been tested clinical trials against cancer. Addition 2536 at concentrations as low 20 nM blocked formation vesicles from cultivated Furthermore, eliminated mature vitro, yielding tissue no longer capable proliferation. Conclusions/Significance: conclude effectively inactivates E. multilocularis cells vitro direct inhibition inducing mitotic arrest killing. Since are decisive for proliferation metastasis within host, related compounds very promising complement chemotherapy.

参考文章(52)
Peter M. Ellis, Quincy S. Chu, Natasha Leighl, Scott A. Laurie, Holger Fritsch, Birgit Gaschler-Markefski, Steve Gyorffy, Gerd Munzert, A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer. Clinical Lung Cancer. ,vol. 14, pp. 19- 27 ,(2013) , 10.1016/J.CLLC.2012.04.003
Martin Steegmaier, Matthias Hoffmann, Anke Baum, Péter Lénárt, Mark Petronczki, Martin Krššák, Ulrich Gürtler, Pilar Garin-Chesa, Simone Lieb, Jens Quant, Matthias Grauert, Günther R Adolf, Norbert Kraut, Jan-Michael Peters, Wolfgang J Rettig, None, BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo Current Biology. ,vol. 17, pp. 316- 322 ,(2007) , 10.1016/J.CUB.2006.12.037
Jerome Vicogne, Katia Cailliau, David Tulasne, Edith Browaeys, Yu Tao Yan, Veronique Fafeur, Jean Pierre Vilain, Dominique Legrand, Jacques Trolet, Colette Dissous, Conservation of epidermal growth factor receptor function in the human parasitic helminth Schistosoma mansoni. Journal of Biological Chemistry. ,vol. 279, pp. 37407- 37414 ,(2004) , 10.1074/JBC.M313738200
Klaus Strebhardt, Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy Nature Reviews Drug Discovery. ,vol. 9, pp. 643- 660 ,(2010) , 10.1038/NRD3184
Markus Spiliotis, Dennis Tappe, Lukas Sesterhenn, Klaus Brehm, Long-term in vitro cultivation of Echinococcus multilocularis metacestodes under axenic conditions Parasitology Research. ,vol. 92, pp. 430- 432 ,(2004) , 10.1007/S00436-003-1046-8
Markus Spiliotis, Chiaki Mizukami, Yuzaburo Oku, Ferenc Kiss, Klaus Brehm, Bruno Gottstein, Echinococcus multilocularis primary cells: Improved isolation, small-scale cultivation and RNA interference Molecular and Biochemical Parasitology. ,vol. 174, pp. 83- 87 ,(2010) , 10.1016/J.MOLBIOPARA.2010.07.001
I. Letunic, T. Doerks, P. Bork, SMART 7: recent updates to the protein domain annotation resource Nucleic Acids Research. ,vol. 40, pp. 302- 305 ,(2012) , 10.1093/NAR/GKR931
Enrico Brunetti, Peter Kern, Dominique Angèle Vuitton, None, Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans Acta Tropica. ,vol. 114, pp. 1- 16 ,(2010) , 10.1016/J.ACTATROPICA.2009.11.001
Patrick Schöffski, Jean-Yves Blay, Jacques De Greve, Etienne Brain, Jean-Pascal Machiels, Jean-Charles Soria, Stefan Sleijfer, Pascal Wolter, Isabelle Ray-Coquard, Christel Fontaine, Gerd Munzert, Holger Fritsch, Gertraud Hanft, Claire Aerts, Jérome Rapion, Anouk Allgeier, Jan Bogaerts, Denis Lacombe, Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma : the first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI) European Journal of Cancer. ,vol. 46, pp. 2206- 2215 ,(2009) , 10.1016/J.EJCA.2010.03.039